Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome

Human immunodeficiency virus type 1 (HIV-1) isolates vary in their in vitro biologic characteristics such as cellular host range, replication kinetics, and cytopathicity. In this study, we molecularly exchanged equivalent regions between two cloned HIV-1 isolates with differing replicative and cytopathic properties. To facilitate generation of recombinant viruses, we used a method involving cotransfection of human monolayer cells with plasmid constructs containing half of the biologically active viral genome. The two halves of the genome were subsequently ligated by intracellular processes to form the complete proviral genome. This method simplifies plasmid construction, since new infectious virus particles can be produced easily from the individual constructs that are correctly ligated in vivo. Results obtained by using recombinant viruses generated in this manner indicate that the ability of HIV to replicate in specific cell types and cytopathicity segregate with the env region of the viral genome.

[1]  B. Chesebro,et al.  Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells , 1990, Journal of virology.

[2]  L. Ratner,et al.  Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells , 1989, Journal of virology.

[3]  J. Levy,et al.  Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Lange,et al.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.

[5]  S. Le,et al.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA , 1989, Nature.

[6]  G. Pavlakis,et al.  The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region , 1989, Journal of virology.

[7]  L. Ratner,et al.  Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Levy,et al.  MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV). , 1988, Virology.

[9]  J. Albert,et al.  Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates , 1988, Journal of virology.

[10]  S. Dewhurst,et al.  Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual , 1988, Journal of virology.

[11]  S. Venkatesan,et al.  Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. , 1988, Science.

[12]  T. Klimkait,et al.  A novel gene of HIV-1, vpu, and its 16-kilodalton product. , 1988, Science.

[13]  David Looney,et al.  Biologically diverse molecular variants within a single HIV-1 isolate , 1988, Nature.

[14]  L. Arthur,et al.  Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Cheng‐Mayer,et al.  Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.

[16]  H. M. Martinez.  A flexible multiple sequence alignment program. , 1988, Nucleic acids research.

[17]  W. Gallaher,et al.  Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus , 1987, Cell.

[18]  C. Cheng‐Mayer,et al.  Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Sodroski,et al.  Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity , 1986, Journal of virology.

[20]  K. Steimer,et al.  Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein , 1986, Nature.

[21]  S. Wain-Hobson,et al.  Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients , 1986, Cell.

[22]  C. Cheng‐Mayer,et al.  AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. , 1986, Science.

[23]  J. Levy,et al.  Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. , 1985, Virology.

[24]  T. Quinn,et al.  Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. , 1985, Science.

[25]  J. Levy,et al.  Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. , 1985, The Journal of infectious diseases.

[26]  S. Arya,et al.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[27]  K. Steimer,et al.  Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). , 1985, Science.

[28]  J. Levy,et al.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. , 1984, Science.

[29]  M. Urdea,et al.  Use of unpurified synthetic deoxynucleotide primers for rapid dideoxynucleotide chain termination sequencing. , 1984, DNA.

[30]  J. Sodroski,et al.  Identification of HIV-1 vpr product and function. , 1990, Journal of acquired immune deficiency syndromes.

[31]  J. Sodroski,et al.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity , 1986, Nature.

[32]  S. J. Potter,et al.  Molecular cloning of AIDS-associated retrovirus , 1984, Nature.